Clinical Trial Update: Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating eltrombopag for treating thrombocytopenia in patients with advanced myelodysplastic syndromes or secondary acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Myelodysplastic Syndrome | Phase 1 | Status: COMPLETED